Data Provide Additional Insight Into the Mode of Action of MAVENCLAD™ (Cladribine Tablets) in Patients With Relapsing MS
– Merck, a leading science and technology company, today announced the presentation of safety and efficacy data on MAVENCLAD™ (Cladribine Tablets) for the treatment of…